TETRAGENETICS
Tetragenetics is an early-stage biotechnology company meeting the needs of customers who seek a cost-effective alternative platform technology for the production of genetically engineered proteins. Their technology is particularly well suited to the production of eucaryotic membrane and secretory proteins that are difficult to express in conventional systems. Such proteins include vaccine antigens, monoclonal antibodies, and a variety of therapeutic proteins for the treatment and prevention of human and animal disease.
TETRAGENETICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2004-01-01
Address:
Ithaca, New York, United States
Country:
United States
Website Url:
http://www.tetragenetics.com
Total Employee:
11+
Status:
Active
Contact:
6174013754
Email Addresses:
[email protected]
Total Funding:
8.09 M USD
Technology used in webpage:
SPF IPv6 Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Google Apps For Business Microsoft Azure DNS Cloudflare DNS DMARC Zoom Video Conferencing
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Swiftscale Biologics
Swiftscale Biologics uses cell-free protein synthesis to enable the next generation of protein therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
JDRF T1D Fund
JDRF T1D Fund investment in Venture Round - Tetragenetics
National Institutes of Health
National Institutes of Health investment in Grant - Tetragenetics
NXT Ventures
NXT Ventures investment in Venture Round - Tetragenetics
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Tetragenetics
Castile Ventures
Castile Ventures investment in Venture Round - Tetragenetics
LaunchPad Venture
LaunchPad Venture investment in Venture Round - Tetragenetics
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Tetragenetics
Excell Partners
Excell Partners investment in Seed Round - Tetragenetics
Excell Partners
Excell Partners investment in Seed Round - Tetragenetics
Boston Harbor Angels
Boston Harbor Angels investment in Angel Round - Tetragenetics
Official Site Inspections
http://www.tetragenetics.com
- Host name: 172.67.175.89
- IP address: 172.67.175.89
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tetragenetics"
TetraGenetics Company Profile 2024: Valuation, Investors
TetraGenetics General Information Description. Developer of a bio-pharmaceutical platform designed to develop novel therapeutics for autoimmune diseases. The company's platform โฆSee details»
Tetragenetics, Inc. | VentureRadar
TetraGenetics is an entrepreneurial biotech company focused on the discovery and development of first-in-class biologic medicines for pain, autoimmune diseases, and fibrosis. The company โฆSee details»
TetraGenetics Company Profile | Management and Employees List
TetraGenetics Profile and History About TetraGenetics: TetraGenetics is focused on the discovery and development of first-in-class biologic medicines for pain, autoimmune diseases, and โฆSee details»
Tetragenetics Inc. Management Team | Org Chart - RocketReach
Tetragenetics Inc. employs 19 employees. The Tetragenetics Inc. management team includes Charlotte McDonagh (SVP, Biotherapeutics Discovery), Kevin O'Brien (Chief Financial โฆSee details»
TETRAGENETICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TETRAGENETICS, INC. of Arlington, MA. Get the latest business insights from Dun & โฆSee details»
TetraGenetics Overview | SignalHire Company Profile
TetraGenetics is a private company that has been in the industry for 20 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. The position โฆSee details»
TetraGenetics - Products, Competitors, Financials, Employees ...
TetraGenetics is an entrepreneurial biotech company focused on the discovery of therapeutics for autoimmune disease and pain. The company specializes in recombinant human ion channel โฆSee details»
AbCellera acquires Tetragenetics - 2021-09-13 - Crunchbase
Tetragenetics Tetragenetics helps people seeking a cost-effective alternative platform technology for the production of genetically engineered proteins. Acquiring Organization: AbCellera โฆSee details»
TetraGenetics Company Profile - Office Locations, Competitors
TetraGenetics is a biotech company focused on the discovery of novel therapeutics for autoimmune disease and pain. The Company is the world leader in recombinant human ion โฆSee details»
Tetragenetics: Revenue, Competitors, Alternatives
Tetragenetics, Inc. is an early-stage biotechnology company meeting the needs of customers who seek a cost-effective alternative platform technology for the production of genetically โฆSee details»
TetraGenetics - Overview, News & Similar companies - ZoomInfo
Apr 27, 2020 TetraGenetics contact info: Phone number: (617) 500-7471 Website: www.tetragenetics.com What does TetraGenetics do? About TetraGenetics: TetraGenetics is โฆSee details»
Nextsource | Company Profile | Tetragenetics
Track key 'champions' at Tetragenetics as they move through different departments or take on new roles. Find out if Tetragenetics is undergoing leadership changes or executive team โฆSee details»
TetraGenetics Inc.: Contact Details and Business Profile
TetraGenetics harnesses the unique capabilities of the protozoa Tetrahymena thermophila to produce recombinant proteins for the biopharmaceutical industry. With our world-class science โฆSee details»
AbCellera Acquires TetraGenetics, Enhancing Capabilities to โฆ
Sep 13, 2021 Acquisition expands AbCelleraโs existing capabilities to unlock difficult-to-drug transmembrane proteins for antibody discovery programs AbCellera (Nasdaq: ABCL), a โฆSee details»
Tetragenetics - Company profile | ensun
Who is Tetragenetics? AbCellera grew out of the idea that single-cell microfluidics and next-generation technologies can radically change how we discover drugs. We are motivated by the โฆSee details»
TetraGenetics Receives Investment from JDRF T1D Fund - T1D โฆ
BOSTON, MA โ May 02, 2017 . TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimmune diseases, today announced it has received an investment in the โฆSee details»
TetraGenetics - T1D Fund: A Breakthrough T1D Venture
TetraGenetics. About The T1D Fund. The T1D Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and ultimately cure T1D. Launched in December โฆSee details»
Tetragenetics | Scientist.com
Tetragenetics Bolton St Marlborough, MA, 01752 United States: Get started If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If โฆSee details»
Tetragenetics Inc. Company Profile- Outlook, Business Segments ...
4 TETRAGENETICS, INC- SWOT PROFILE 4.1 Strengths 4.2 Weaknesses 4.3 Opportunities 4.4 Threats 5 TETRAGENETICS, INC- OUTLOOK STATEMENT 6 TETRAGENETICS, INC- โฆSee details»